纳洛酮索赔与独立药店和连锁药店比例之间的关联:美国纳洛酮索赔的纵向分析。
The association between naloxone claims and proportion of independent versus chain pharmacies: A longitudinal analysis of naloxone claims in the United States.
出版信息
J Am Pharm Assoc (2003). 2024 Jul-Aug;64(4):102093. doi: 10.1016/j.japh.2024.102093. Epub 2024 Apr 10.
BACKGROUND
Expanding access to naloxone through pharmacies is an important policy goal. Our objective was to characterize national county-level naloxone dispensing of chain versus independent pharmacies.
METHODS
The primary exposure in our longitudinal analysis was the proportion of chain pharmacies in a county, identified through the U.S. Department of Homeland Security 2010 Infrastructure Foundation-Level Data. We defined counties as having "higher proportion" of chain pharmacies if at least 50% of pharmacies were large national chains. The primary outcome was quarter-year (2016Q1-2019Q2) rate of pharmacy naloxone claims per 100,000 persons from Symphony Health at the county level. We compared the naloxone dispensing rate between county types using 2-sample t tests. We estimated the association between county-level chain pharmacy proportion and rate of naloxone claims using a linear model with year-quarter fixed effects.
RESULTS
Nearly one-third of counties (n = 946) were higher proportion. Higher proportion counties had a significantly higher rate of naloxone claims across the study period, in 4 of 6 urban-rural classifications, and in counties with and without naloxone access laws (NALs). The linear model confirmed that higher proportion counties had a significantly higher rate of naloxone claims, adjusting for urban-rural designation, income, population characteristics, opioid mortality rate, coprescribing laws, and NALs.
CONCLUSION
In this national study, we found an association between naloxone dispensing rates and the county-level proportion of chain (vs. independent) pharmacies. Incentivizing naloxone dispensing through educational, regulatory, or legal efforts may improve naloxone availability and dispensing rates-particularly in counties with proportionately high numbers of independent pharmacies.
背景
通过药店扩大纳洛酮的获取途径是一个重要的政策目标。我们的目标是描述全国县级连锁药店和独立药店的纳洛酮配药情况。
方法
在我们的纵向分析中,主要暴露因素是一个县的连锁药店比例,通过美国国土安全部 2010 年基础设施基础数据确定。我们将至少 50%的药店为大型全国连锁店的县定义为“连锁药店比例较高”。主要结果是每个县每季度(2016 年第一季度至 2019 年第二季度)从 Symphony Health 获得的药店纳洛酮配药率,以每 10 万人为单位。我们使用 2 样本 t 检验比较了不同县类型的纳洛酮配药率。我们使用具有年季度固定效应的线性模型,估计了县级连锁药店比例与纳洛酮配药率之间的关联。
结果
近三分之一的县(n=946)属于连锁药店比例较高的县。在整个研究期间,在 6 个城乡分类中的 4 个,以及在有和没有纳洛酮获取法(NAL)的县中,连锁药店比例较高的县的纳洛酮配药率都显著较高。线性模型证实,在调整了城乡指定、收入、人口特征、阿片类药物死亡率、共同处方法和 NAL 后,连锁药店比例较高的县的纳洛酮配药率显著较高。
结论
在这项全国性研究中,我们发现纳洛酮配药率与县级连锁(与独立)药店比例之间存在关联。通过教育、监管或法律手段激励纳洛酮配药,可能会提高纳洛酮的可及性和配药率,特别是在独立药店比例较高的县。